Bilimsel çalışmalar

Doç. Dr. Tanju Berber

32 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study

    Medicine, 2026

    DOI 10.1097/md.0000000000048711 PMID 42116366 Açık erişimli tam metinKaynak: OpenAlex

  2. Malignant Phosphaturic Mesenchymal Tumor With Lung Metastasis

    Cureus, 2026

    DOI 10.7759/cureus.102504 PMID 41769508 Açık erişimli tam metinKaynak: OpenAlex

  3. High Overall Performance but Limited Multidisciplinary Depth: A Cross- Sectional Evaluation of ChatGPT in Pathological Fractures of Plasma Cell Tumors

    Research Square, 2026

    DOI 10.21203/rs.3.rs-9628103/v1 Açık erişimli tam metinKaynak: OpenAlex

  4. Unsupervised Clustering Successfully Predicts Prognosis in NSCLC Brain Metastasis Cohorts

    Diagnostics, 2025

    DOI 10.3390/diagnostics15141747 PMID 40722497 4 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  5. Stereotactic radiosurgery vs. fractionated radiotherapy for large vestibular schwannomas: should FSRT be the preferred treatment?

    Clinical and Translational Oncology, 2024

    DOI 10.1007/s12094-024-03790-0 PMID 39676098 Kaynak: ORCID

  6. Stereotactic Body Radiotherapy Reirradiation Is Safe in Patients With Lung Cancer With In-Field Enlarged Tumor Recurrence

    Technology in Cancer Research & Treatment, 2024

    DOI 10.1177/15330338231208616 PMID 38860536 Açık erişimli tam metinKaynak: ORCID

  7. A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study ( TROD 01‐001)

    Head & Neck, 2023

    DOI 10.1002/hed.27333 PMID 36854873 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  8. The Prognostic Values of Graded Prognostic Assessment (GPA) Index In Advanced Stage NSCLC Patients With Brain Metastasis

    Turkish Journal of Clinics and Laboratory, 2023

    DOI 10.18663/tjcl.1240361 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  9. Results of salvage treatment with CyberKnife® fractioned radiosurgery in recurrent large chordoma

    European Spine Journal, 2023

    DOI 10.1007/s00586-022-07399-1 PMID 36180739 7 atıf (Europe PMC) Kaynak: ORCID

  10. Postoperative pelvic irradiation and vaginal brachytherapy in stage II endometrial cancer

    Annals of Clinical and Analytical Medicine, 2023

    DOI 10.4328/acam.21529 Açık erişimli tam metinKaynak: ORCID

  11. Impact of Adjuvant Chemotherapy in Patients with Medically Inoperable Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy

    Journal of Oncological Sciences, 2023

    DOI 10.37047/jos.2023-95681 Açık erişimli tam metinKaynak: OpenAlex

  12. Radiosurgery effects and adverse effects in symptomatic eloquent brain-located Cavernomas

    Journal of Radiation Research, 2022

    DOI 10.1093/jrr/rrac056 PMID 36208871 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  13. Role of Consolidative Stereotactic Body Radiation Therapy in Oligoresistant/Oligoprogressive Pulmonary Parenchymal Metastases

    Cancer Management and Research, 2022

    DOI 10.2147/cmar.s360766 PMID 36068821 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  14. Extreme hypofractıonated radiosurgery in recurrent inoperable High -Grade Ultra -Large gliomas

    International Journal of Radiation Research,, 2022

    Kaynak: ORCID

  15. Extreme hypofractionated radiosurgery in recurrent inoperable High-Grade Ultra-Large gliomas

    International Journal of Radiation Research, 2022

    DOI 10.52547/ijrr.20.3.18 Kaynak: ORCID

  16. Multi-institutional review of SBRT for adrenal metastasis: Turkish Radiation Oncology Society Study

    Radiotherapy and Oncology, 2022

    Kaynak: ORCID

  17. Stereotactic radiotherapy for adrenal metastases: a multi-institutional review of patient characteristics and outcomes. Turkish Society for Radiation Oncology SBRT Group Study (TROD SBRT 10-004)

    Oncology Research and Treatment, 2022

    DOI 10.1159/000527052 PMID 36116432 5 atıf (Europe PMC) Kaynak: ORCID

  18. Organ At Risk (OAR) Data on Clinical Toxicity in The Treatment of Bulky Adrenal Metastases With Stereotactic Ablative Radiotherapy (SABR)

    Research Square, 2022

    DOI 10.21203/rs.3.rs-1356246/v1 Açık erişimli tam metinKaynak: OpenAlex

  19. PO-1440 Multi-institutional review of SBRT for adrenal metastasis: Turkish Radiation Oncology Society Study

    Radiotherapy and Oncology, 2022

    DOI 10.1016/s0167-8140(22)03404-1 Kaynak: OpenAlex

  20. Organ At Risk (OAR) Data on Clinical Toxicity in The Treatment of Bulky Adrenal Metastases With Stereotactic Ablative Radiotherapy (SABR)

    Research Square, 2022

    DOI 10.21203/rs.3.rs-1356246/v2 Açık erişimli tam metinKaynak: OpenAlex

  21. Onkolojik Aciller

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.243 Kaynak: OpenAlex

  22. Clinical outcome after CyberKnife® radiosurgery re-irradiation for recurrent brain metastases

    Cancer/Radiothérapie, 2021

    DOI 10.1016/j.canrad.2021.02.003 PMID 33752961 7 atıf (Europe PMC) Kaynak: ORCID

  23. The efficacy and tolerability of ultra-hypofractionated radiotherapy in low-intermediate risk prostate cancer patients: single center experience

    The Aging Male, 2021

    DOI 10.1080/13685538.2021.1948992 PMID 34233569 6 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  24. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study

    The Clinical Respiratory Journal, 2020

    DOI 10.1111/crj.13240 PMID 32749053 2 atıf (Europe PMC) Kaynak: OpenAlex

  25. Retrospective Evaluation of Patients Diagnosed with Stage I-II Supradiaphragmatic Presentation Hodgkin’s Lymphoma: Treatment Effect and Late-side Effect

    European Archives of Medical Research, 2020

    DOI 10.4274/eamr.galenos.2019.74745 Açık erişimli tam metinKaynak: ORCID

  26. Dosimetric Comparison of Radiotherapy Techniques for Treating Early-stage Glottic Larynx Cancer

    Journal of Academic Research in Medicine, 2020

    DOI 10.4274/jarem.galenos.2018.2508 Açık erişimli tam metinKaynak: ORCID

  27. The Retrospective Evaluation of The Local Tumor Control and Adverse Effects of Treatment in Patients Treated Using Cyberknife Stereotactic Radiotherapy in Vestibular Schwannomas

    Journal of Academic Research in Medicine, 2020

    DOI 10.4274/jarem.galenos.2018.2536 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  28. National, Observational, Multicentric Retrospective Study to Understand Treatment Patterns, Patient Journey and Characteristics with Stage III Non-Small Cell Lung Cancer Patients in Turkey: Stone Trial

    International Journal of Radiation Oncology*Biology*Physics, 2020

    DOI 10.1016/j.ijrobp.2020.07.1347 Açık erişimli tam metinKaynak: OpenAlex

  29. EP1.16-07 National, Observational, Multicentric Study in Stage III Non-Small Cell Lung Cancer Patients in Turkey: Stone Trial

    Journal of Thoracic Oncology, 2019

    DOI 10.1016/j.jtho.2019.08.2372 Açık erişimli tam metinKaynak: OpenAlex

  30. Results of Vestibular Schwannomas Treated By Cyberknife® and Stereotactic Radiotherapy: A Retrospective Study

    Journal of Academic Research in Medicine, 2018

    DOI 10.5152/jarem.2018.2536 Kaynak: OpenAlex

  31. Raltitrexed concomitant with radiotherapy as neoadjuvant treatment in patients with locally advanced rectal carcinoma: A phase II study

    Turk Onkoloji Dergisi, 2009

    Kaynak: ORCID

  32. Raltitrexed concomitant with radiotherapy as neoadjuvant treatment in patients with locally advanced rectal carcinoma: a phase II study

    TURKISH JOURNAL OF ONCOLOGY, 2009

    Kaynak: ORCID